MDCorp (MDCX) P/E (2024 - 2026)
MDCorp (MDCX) P/E from Nov 14, 2024 to Jul 21, 2026. The TTM MDCorp (MDCX) P/E is -0.30. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of MDCorp (MDCX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.30 | -73.56% |
| 2025 | -1.13 | -42.02% |
| 2024 | -1.95 | N/A |
Comparison MDCorp (MDCX) P/E with competitors
MDCorp (MDCX) P/E is -0.30.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 10.11 | -3472.90% |
| PFE | Pfizer Inc | 11.65 | -3988.22% |
| NVO | Novo Nordisk | 11.79 | -4034.03% |
| GSK | GSK Plc | 12.10 | -4138.29% |
| SNY | Sanofi | 12.12 | -4145.13% |
| BMY | Bristol-Myers Squibb Company | 13.82 | -4710.67% |
| OGN | Organon & Company | 14.33 | -4880.03% |
| BIIB | Biogen Inc | 17.41 | -5907.15% |
| GILD | Gilead Sciences Inc | 17.75 | -6020.38% |
| NVS | Novartis AG | 21.60 | -7305.54% |
| JNJ | Johnson & Johnson | 22.09 | -7469.35% |
| AMGN | AMGEN Inc | 24.75 | -8357.88% |
| MRK | Merck & Co Inc | 26.93 | -9083.83% |
| AZN | Astrazeneca plc | 28.44 | -9589.62% |
| LLY | Lilly(Eli) & Company | 48.44 | -16262.41% |
| ABBV | Abbvie Inc | 139.08 | -46502.56% |